These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 8583463

  • 1. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC, Fitzpatrick V, Chrysant S, Francischetti EA, Goldberg AI, Sweet CS.
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [Abstract] [Full Text] [Related]

  • 2. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS.
    Arch Intern Med; 1996 Feb 12; 156(3):278-85. PubMed ID: 8572837
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J.
    Clin Ther; 1996 Feb 12; 18(4):608-25. PubMed ID: 8879890
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B, Keller SE, Makris L, Goldberg AI, Sweet CS, Lim NY.
    Am J Hypertens; 1995 Jun 12; 8(6):578-83. PubMed ID: 7662242
    [Abstract] [Full Text] [Related]

  • 5. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
    Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS.
    Blood Press; 1996 Jan 12; 5(1):32-40. PubMed ID: 8777471
    [Abstract] [Full Text] [Related]

  • 6. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 12; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 12; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug 12; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 12; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
    Clin Ther; 2006 Oct 12; 28(10):1639-48. PubMed ID: 17157119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH, Reams GP, Wu Z, Lau-Sieckman A.
    J Hum Hypertens; 1995 Apr 12; 9(4):237-43. PubMed ID: 7595905
    [Abstract] [Full Text] [Related]

  • 15. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 12; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
    Townsend R, Haggert B, Liss C, Edelman JM.
    Clin Ther; 1995 Jan 12; 17(5):911-23. PubMed ID: 8595643
    [Abstract] [Full Text] [Related]

  • 17. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    Clin Ther; 1996 Jan 12; 18(3):411-28. PubMed ID: 8829017
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of losartan.
    Goldberg A, Sweet C.
    Can J Cardiol; 1995 Aug 12; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M, Hosoai H, Ikewaki K, Ayaori M, Yamashita T, Shige H, Higashi K, Nashida Y, Shimizu S, Kijima F, Yokoyama M, Nakamura H, ABC Study Group.
    Clin Ther; 2013 Apr 12; 35(4):461-73. PubMed ID: 23490288
    [Abstract] [Full Text] [Related]

  • 20. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP, Sareli P, Marin F, Aroca-Martinez G, Maritz FJ, Jardim PC, Guerrero AA, Thompson CA, Bero T, Drazka J, Kosmalova V, Dumortier T, Smith RD.
    Adv Ther; 1999 Apr 12; 16(5):187-99. PubMed ID: 10915394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.